Today on the show, can GLP-1s save employers money in the long run
Nutrient Density: Because you will be eating less food, every bite counts
In the process, we aim to help patients better understand how insurance works so they can advocate for themselves with confidence, now and in the future
Nevertheless, even the most effective marketed incretin, the GLP-1/GIP dual agonist tirzepatide, produces a maximum HbA1c reduction of ~2.6%, with fewer than half of participants in the SURPASS trials reaching normoglycemia (HbA1c 10%), vehicle-treated animals lost ~40% of body weight over 3 months, consistent with prior reports showing comparable reductions from ~40 g at week 10 to ~25 g by week 20 19
These innovative peptides simultaneously activate these receptors, demonstrating significant potential in preclinical and early clinical trials [104,105,106]
6 mm and 8 mm are mostly leftover diabetes-era stock